- Telehealth Visits
- Insurance plan information
Sienna Kurland, MD, MPH
She | Her | HersInternal Medicine- Telehealth Visits
- Insurance plan information
Sienna Kurland, MD, MPH
She | Her | HersInternal Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Sienna Kurland is an internal medicine specialist who provides primary care to adults.
Kurland earned her medical degree and a master of public health degree at Tulane University School of Medicine. She completed a residency in internal medicine at New York University Grossman School of Medicine, where she also served as chief resident.
In addition to caring for her patients, Kurland enjoys teaching and supervising residents at UCSF.
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, New York University School of Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224232%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224232%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 60 reviews
- December 18, 20255 out of 5 Stars
Dr. K is a gem
- November 24, 20255 out of 5 Stars
Every step of the way, everything was done quite well and very professions and very friendly
- November 24, 20255 out of 5 Stars
Dr. Kurland and her assistant, Ira, are super great at what they each do.
- November 24, 20255 out of 5 Stars
Dr. Knows her stuff. Explains things practically and why treatment and certain courses of action are important.
- November 8, 20255 out of 5 Stars
Dr. Kurland is so professional and yet still maintains a warm demeanor!
- November 4, 20255 out of 5 Stars
Very caring
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.